Results 281 to 290 of about 2,171,591 (317)
Some of the next articles are maybe not open access.

Inhibitors of chitinases

1999
In this review we describe inhibition of chitinases from bacteria, fungi, plants and animals by allosamidin and its derivatives, cyclic peptides, styloguanidin and divalent cations. Most information is available for allosamidin, whose important structural features necessary for inhibition are known. At least one N-acetylallosamine sugar must be present,
K D, Spindler, M, Spindler-Barth
openaire   +2 more sources

Epigenetic Inhibitors

2014
Traditional treatments for cancer include chemotherapy, radiation therapy, and surgery. Recently, epigenetic inhibitors have been found to be very effective in cancer treatment. Epigenetic changes such as DNA methylation, histone deacetylation, and microRNA (miRNA) expression are capable of silencing the expression of tumor suppressor genes and ...
Mukesh, Verma, Hirendra Nath, Banerjee
openaire   +2 more sources

[Motility inhibitors and secretion inhibitors].

Schweizerische medizinische Wochenschrift. Supplementum, 1985
Antidiarrheal substances interfering with either intestinal motility or intestinal secretion have been used for the management of acute diarrhea. Opiates are the motility inhibitors that appear particularly useful and among these drugs loperamide is the drug of choice due to its low risk of side effects.
openaire   +1 more source

Corrosion Inhibitors

2018
Advances in the field of corrosion inhibitors proceed in two main directions: (i) development of eco-friendly effective treatments and (ii) production of “smart” coatings. The first issue is connected to the more strict regulations regarding corrosion inhibitors application, due to environmental concerns.
openaire   +1 more source

Renin Inhibitors

2006
S H, Rosenberg, H D, Kleinert
openaire   +2 more sources

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap   +2 more
exaly  

Cysteine Proteases and Their Inhibitors

Chemical Reviews, 1997
Hans-Hartwig Otto, Tanja Schirmeister
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

Ca-A Cancer Journal for Clinicians, 2005
R M O'Regan   +2 more
exaly  

Home - About - Disclaimer - Privacy